Investor Relations

Overview

Investor Relations

DiaKine Therapeutics, Inc. is a seed-stage company developing therapies addressing type 1 and type 2 diabetes and related complications, with market opportunities exceeding $13 billion.

DiaKine Therapeutics • 338 Raleigh Ave. • Norfolk VA 23507 •info@diakine.com

©2012 DiaKine Therapeutics. All rights reserved.
Web site designed, developed and hosted by Atlanta Web Service LLC.
For technical questions or comments about this site, contact the Webmaster.